DermTech/DMTK

$1.31

5.27%
-
1D1W1MYTD1YMAX

About DermTech

DermTech, Inc. is a molecular diagnostics company. The Company is focused on developing and marketing non-invasive genomics tests to aid in the diagnosis and management of skin cancer, inflammatory skin diseases, and aging-related skin conditions. Its technology enhances early melanoma detection by non-invasively detecting genomic markers associated with melanoma to identify higher risk lesions at their earliest stages to rule out melanoma. It provides genomic analysis of skin samples collected non-invasively using its Smart Stickers. Its DermTech Melanoma Test (the DMT) facilitates the clinical assessment of pigmented skin lesions that raise the concern for melanoma. Its commercial test addresses unmet needs in the diagnostic pathway of pigmented skin lesions, dark-colored patches of skin often referred to as moles. It markets the DMT under the name Pigmented Lesion Assay (PLA). It is also focuses on products to assess precancerous genomic changes associated with UV sun exposure.

Ticker

DMTK

Sector

Healthcare

Trading on

NASDAQ

Industry

Business Services

CEO

Bret Christensen

Employees

278

Headquarters

San diego, United States

Website

-

DermTech Metrics

BasicAdvanced
$43.49M
Market cap
-
P/E ratio
-$3.51
EPS
2.58
Beta
-
Dividend rate

What the Analysts think about DermTech

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
174.81% upside
High $4.50
Low $2.50
$1.31
Current price
$3.60
Average price target

DermTech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-489.74% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$3.9M
0%
Net income
$-19.1M
-38.98%
Profit margin
-489.74%
-38.98%

DermTech Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 24.84%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.93
-$1.02
-$0.99
-$0.57
-
Expected
-$0.96
-$0.91
-$0.97
-$0.76
-$0.57
Surprise
-3.41%
12.44%
1.71%
-24.84%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell DermTech stock

Buy or sell DermTech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing